Insider Trading: Emergent BioSolutions Inc (EBS)

EBS on New York Consolidated

21.80USD
19 Sep 2014
Price Change (% chg)

$-0.40 (-1.80%)
Prev Close
$22.20
Open
$22.24
Day's High
$22.47
Day's Low
$21.62
Volume
433,998
Avg. Vol
203,914
52-wk High
$28.48
52-wk Low
$17.31

Search Stocks
HAVEY ADAM Options Exercised: 1,336
Trade Date: Monday, 10 Mar 2014 Price: 15.83
Title: Officer Shares Held: 36,920
Type Traded: Direct Net Change in Shares This Filing: 6,889

Institutional Holders

% Shares Owned: 78.04%
# of Holders: 211
Total Shares Held: 29,246,414
3 Mo. Net Change: 239,433
# New Positions: 26
# Closed Positions: 30
# Increased Positions: 113
# Reduced Positions: 93
# Net Buyers: 20

Officers & Directors

Name Age Since Current Position

Fuad El-Hibri

56 2012 Executive Chairman of the Board

Daniel Abdun-Nabi

59 2012 President, Chief Executive Officer, Director

Robert Kramer

56 2012 Chief Financial Officer, Interim Executive Vice President - Corporate Services Division, Principal Financial and Accounting Officer, Treasurer

Anatolio Cruz

53 2014 Executive Vice President, General Counsel, Corporate Secretary

Adam Havey

43 2011 Executive Vice President, President - BioDefense Division

Barry Labinger

50 2013 Executive Vice President, President - Biosciences Division

Ronald Richard

58 2011 Lead Independent Director

Sue Bailey

70 2007 Independent Director

Zsolt Harsanyi

70 2004 Independent Director

George Joulwan

74 2013 Independent Director

John Niederhuber

75 2010 Independent Director

Louis Sullivan

80 2011 Independent Director

Marvin White

52 2010 Independent Director

Robert Burrows

IR Contact Officer
Search Stocks